Oxytocin-secreting system: A major part of the neuroendocrine center regulating immunologic activity

Journal of Neuroimmunology

Volumn 289, Issue , 2015, Pages 152-161

  Wang, Ping ^a   Yang, Hai Peng ^a   Tian, Shujun ^a   Wang, Liwei ^a   Wang, Stephani C ^b   Zhang, Fengmin ^a   Wang, Yu Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

Behavior; Cytokine; Hormone; Hypothalamus; Neuroendocrinoimmunology; Oxytocin; Paraventricular nucleus; Supraoptic nucleus; Thymus

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CANNABINOID 1 RECEPTOR; CIPROFLOXACIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTYL AMINOPEPTIDASE; GLUCOCORTICOID; INDOMETACIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYTOCIN; OXYTOCIN RECEPTOR; PROBIOTIC AGENT; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; THYMUS EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ABORTION; ABSCESS; ABSENCE OF SIDE EFFECTS; ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIULCER ACTIVITY; ANXIETY DISORDER; ASTHMA; BIRTH; BREAST CANCER; BREAST CARCINOGENESIS; BURN; CARCINOMA CELL; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CELLULAR SECRETION; CHORIOAMNIONITIS; COLITIS; CYTOKINE RELEASE; DEPRESSION; DIABETES MELLITUS; DIABETIC FOOT; DISEASE MARKER; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; ENDOTOXEMIA; ENZYME ACTIVITY; HEART DISEASE; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; HYPOTHALAMIC OXYTOCIN-SECRETING SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; INFLAMMATORY HEART DISEASE; LABOR; LACTATION; LOBECTOMY; LYMPHOCYTE DIFFERENTIATION; MENTAL DISEASE; MOLECULAR INTERACTION; MULTIPLE SCLEROSIS; NERVE CELL; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OSSIFICATION; OSTEOSARCOMA; OVARY CARCINOMA; OXIDATIVE STRESS; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PARAVENTRICULAR THALAMIC NUCLEUS; PATHOPHYSIOLOGY; PITUITARY LOBECTOMY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; STOMACH INJURY; SUPRAOPTIC NUCLEUS; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY; TREATMENT DURATION; TUMOR GROWTH; WOUND; WOUND HEALING; ANIMAL; BRAIN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; NEUROSECRETION; PHYSIOLOGY;

ANIMALS; BRAIN; HUMANS; IMMUNE SYSTEM; NEUROSECRETORY SYSTEMS; OXYTOCIN;

EID: 84947938719     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.11.001     Document Type: Review

References (130)

1. Alexander S.L., Irvine C.H. The effect of endotoxin administration on the secretory dynamics of oxytocin in follicular phase mares: relationship to stress axis hormones. J. Neuroendocrinol. 2002, 14:540-548.
2. Amrani Y., Syed F., Huang C., Li K., Liu V., Jain D., et al. Expression and activation of the oxytocin receptor in airway smooth muscle cells: regulation by TNFalpha and IL-13. Respir. Res. 2010, 11:104.
3. Bealer S.L., Armstrong W.E., Crowley W.R. Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R452-R458.
4. Beauquis J., Homo-Delarche F., Revsin Y., De Nicola A.F., Saravia F. Brain alterations in autoimmune and pharmacological models of diabetes mellitus: focus on hypothalamic-pituitary-adrenocortical axis disturbances. Neuroimmunomodulation 2008, 15:61-67.
5. Biyikli N.K., Tugtepe H., Sener G., Velioglu-Ogunc A., Cetinel S., Midillioglu S., et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via a neutrophil-dependent mechanism. Peptides 2006, 27:2249-2257.
6. Bonnyns M., McKenzie J.M. Interactions of stress and endocrine status on rat peripheral lymphocyte responsiveness to phytomitogens. Psychoneuroendocrinology 1979, 4:67-73.
7. Broadbent E., Koschwanez H.E. The psychology of wound healing. Curr. Opin. Psychiatry. 2012, 25:135-140.
8. Brown C.H., Bains J.S., Ludwig M., Stern J.E. Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms. J. Neuroendocrinol. 2013, 25:678-710.
9. Brunton P.J., Arunachalam S., Russel J.A. Control of neurohypophysial hormone secretion, blood osmolality and volume in pregnancy. J. Physiol. Pharmacol. 2008, 59(Suppl 8):27-45.
10. Brunton P.J., Bales J., Russell J.A. Allopregnanolone and induction of endogenous opioid inhibition of oxytocin responses to immune stress in pregnant rats. J. Neuroendocrinol. 2012, 24:690-700.
11. Brunton P.J., Sabatier N., Leng G., Russell J.A. Suppressed oxytocin neuron responses to immune challenge in late pregnant rats: a role for endogenous opioids. Eur. J. Neurosci. 2006, 23:1241-1247.
12. Burbach J.P., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 2001, 81:1197-1267.
13. Campos-Rodriguez R., Quintanar-Stephano A., Jarillo-Luna R.A., Oliver-Aguillon G., Ventura-Juarez J., Rivera-Aguilar V., et al. Hypophysectomy and neurointermediate pituitary lobectomy reduce serum immunoglobulin M (IgM) and IgG and intestinal IgA responses to Salmonella enterica serovar Typhimurium infection in rats. Infect. Immun. 2006, 74:1883-1889.
14. Carnio E.C., Moreto V., Giusti-Paiva A., Antunes-Rodrigues J. Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocr. Metab. Immune. Disord. Drug Targets. 2006, 6:137-142.
15. Carrera-Gonzalez M.P., Ramirez-Exposito M.J., de Saavedra J.M., Sanchez-Agesta R., Mayas M.D., Martinez-Martos J.M. Hypothalamus-pituitary-thyroid axis disruption in rats with breast cancer is related to an altered endogenous oxytocin/insulin-regulated aminopeptidase (IRAP) system. Tumour Biol. 2011, 32:543-549.
16. Cassoni P., Catalano M.G., Sapino A., Marrocco T., Fazzari A., Bussolati G., et al. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells. Int. J. Oncol. 2002, 21:375-378.
17. Cassoni P., Marrocco T., Bussolati B., Allia E., Munaron L., Sapino A., et al. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. Mol. Cancer Res. 2006, 4:351-359.
18. Cassoni P., Sapino A., Marrocco T., Chini B., Bussolati G. Oxytocin and oxytocin receptors in cancer cells and proliferation. J. Neuroendocrinol. 2004, 16:362-364.
19. Chang E.Y., Zhang J., Sullivan S., Newman R., Singh I. N-acetylcysteine prevents preterm birth by attenuating the LPS-induced expression of contractile associated proteins in an animal model. J. Matern. Fetal. Neonatal. Med. 2012, 25:2395-2400.
20. Clodi M., Vila G., Geyeregger R., Riedl M., Stulnig T.M., Struck J., et al. Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E686-E691.
21. Colaianni G., Sun L., Zaidi M., Zallone A. Oxytocin and bone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307:R970-R977.
22. Conde G.L., Renshaw D., Zubelewicz B., Lightman S.L., Harbuz M.S. Central LPS-induced c-fos expression in the PVN and the A1/A2 brainstem noradrenergic cell groups is altered by adrenalectomy. Neuroendocrinology 1999, 70:175-185.
23. De Laurentiis A., Fernandez Solari J., Mohn C., Zorrilla Zubilete M., Rettori V. Endocannabinoid system participates in neuroendocrine control of homeostasis. Neuroimmunomodulation 2010, 17:153-156.
24. Dery M.C., Chaudhry P., Leblanc V., Parent S., Fortier A.M., Asselin E. Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein. Biol. Reprod. 2011, 85:1133-1142.
25. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005, 146:4292-4301.
26. Elabd C., Basillais A., Beaupied H., Breuil V., Wagner N., Scheideler M., et al. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 2008, 26:2399-2407.
27. Elands J., Resink A., De Kloet E.R. Neurohypophyseal hormone receptors in the rat thymus, spleen, and lymphocytes. Endocrinology 1990, 126:2703-2710.
28. Erdman S.E., Poutahidis T. Probiotic 'glow of health': it's more than skin deep. Benefic. Microbes 2014, 1-11.
29. Erkanli Senturk G., Erkanli K., Aydin U., Yucel D., Isiksacan N., Ercan F., et al. The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides 2013, 40:82-88.
30. Fang X., Wong S., Mitchell B.F. Effects of LPS and IL-6 on oxytocin receptor in non-pregnant and pregnant rat uterus. Am. J. Reprod. Immunol. 2000, 44:65-72.
31. Fekete E.M., Antoni M.H., Lopez C., Mendez A.J., Szeto A., Fletcher M.A., et al. Stress buffering effects of oxytocin on HIV status in low-income ethnic minority women. Psychoneuroendocrinology 2011, 36:881-890.
32. Feldman R. Sensitive periods in human social development: new insights from research on oxytocin, synchrony, and high-risk parenting. Dev. Psychopathol. 2015, 27:369-395.
33. Garcia F.D., Coquerel Q., Kiive E., Dechelotte P., Harro J., Fetissov S.O. Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011, 35:118-125.
34. Gavrilenko V.G., Esipov V.K., Sivozhelezov K.G. Morphological characteristic of wound healing process in patients with diabetic purulent-necrotic foot lesion treated with oxytocin. Morfologiia 2003, 124:24-27.
35. Gavrilenko V.G., Fadeev S.B., Bukharin O.V., Kartashova O.L., Kirgizova S.B. Microbiological specifics in the course of suppurative inflammatory processes in soft tissues of patients with diabetes mellitus. Vestn. Khir. Im. I. I. Grek. 2001, 160:39-41.
36. Gaykema R.P., Goehler L.E. Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav. Immun. 2011, 25:443-460.
37. Gaykema R.P., Park S.M., McKibbin C.R., Goehler L.E. Lipopolysaccharide suppresses activation of the tuberomammillary histaminergic system concomitant with behavior: a novel target of immune-sensory pathways. Neuroscience 2008, 152:273-287.
38. Geenen V., Bodart G., Henry S., Michaux H., Dardenne O., Charlet-Renard C., et al. Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity. Front. Neurosci. 2013, 7:187.
39. Geenen V., Legros J.J., Franchimont P., Baudrihaye M., Defresne M.P., Boniver J. The neuroendocrine thymus: coexistence of oxytocin and neurophysin in the human thymus. Science 1986, 232:508-511.
40. Geenen V., Martens H., Brilot F., Renard C., Franchimont D., Kecha O. Thymic neuroendocrine self-antigens. Role in T-cell development and central T-cell self-tolerance. Ann. N. Y. Acad. Sci. 2000, 917:710-723.
41. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
42. Goehler L.E., Park S.M., Opitz N., Lyte M., Gaykema R.P. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 2008, 22:354-366.
43. Grinevich V., Knobloch-Bollmann H.S., Eliava M., Busnelli M., Chini B. Assembling the puzzle: pathways of oxytocin signaling in the brain. Biol. Psychiatry 2015.
44. Hansenne I. Thymic transcription of neurohypophysial and insulin-related genes: impact upon T-cell differentiation and self-tolerance. J. Neuroendocrinol. 2005, 17:321-327.
45. Hansenne I., Rasier G., Pequeux C., Brilot F., Renard C., Breton C., et al. Ontogenesis and functional aspects of oxytocin and vasopressin gene expression in the thymus network. J. Neuroimmunol. 2005, 158:67-75.
46. Hatton G.I., Wang Y.F. Neural mechanisms underlying the milk ejection burst and reflex. Prog. Brain Res. 2008, 170:155-166.
47. Hatton G.I., Yang Q.Z. Ionotropic histamine receptors and H2 receptors modulate supraoptic oxytocin neuronal excitability and dye coupling. J. Neurosci. 2001, 21:2974-2982.
48. Herman A.P., Krawczynska A., Bochenek J., Haziak K., Antushevitch H., Herman A., et al. Inhibition of acetylcholinesterase activity by rivastigmine decreases lipopolysaccharide-induced IL-1beta expression in the hypothalamus of ewes. Domest. Anim. Endocrinol. 2013, 44:109-114.
49. Hirasawa M., Schwab Y., Natah S., Hillard C.J., Mackie K., Sharkey K.A., et al. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J. Physiol. 2004, 559:611-624.
50. Houshmand F., Faghihi M., Zahediasl S. Role of Atrial Natriuretic Peptide in Oxytocin Induced Cardioprotection. Heart lung Circ 2014.
51. Hua R., Pease J.E., Cheng W., Sooranna S.R., Viney J.M., Nelson S.M., et al. Human labour is associated with a decline in myometrial chemokine receptor expression: the role of prostaglandins, oxytocin and cytokines. Am. J. Reprod. Immunol. 2013, 69:21-32.
52. Huitinga I., Schmidt E.D., van der Cammen M.J., Binnekade R., Tilders F.J. Priming with interleukin-1beta suppresses experimental allergic encephalomyelitis in the Lewis rat. J. Neuroendocrinol. 2000, 12:1186-1193.
53. Huitinga I., van der Cammen M., Salm L., Erkut Z., van Dam A., Tilders F., et al. IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis. J. Neuroimmunol. 2000, 107:8-20.
54. Imanieh M.H., Bagheri F., Alizadeh A.M., Ashkani-Esfahani S. Oxytocin has therapeutic effects on cancer, a hypothesis. Eur. J. Pharmacol. 2014, 741C:112-123.
55. Iseri S.O., Dusunceli F., Erzik C., Uslu B., Arbak S., Yegen B.C. Oxytocin or social housing alleviates local burn injury in rats. J. Surg. Res. 2010, 162:122-131.
56. Iseri S.O., Gedik I.E., Erzik C., Uslu B., Arbak S., Gedik N., et al. Oxytocin ameliorates skin damage and oxidant gastric injury in rats with thermal trauma. Burns 2008, 34:361-369.
57. Iseri S.O., Sener G., Saglam B., Gedik N., Ercan F., Yegen B.C. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J. Surg. Res. 2005, 126:73-81.
58. Jankowski M., Bissonauth V., Gao L., Gangal M., Wang D., Danalache B., et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res. Cardiol. 2010, 105:205-218.
59. Karelina K., Stuller K.A., Jarrett B., Zhang N., Wells J., Norman G.J., et al. Oxytocin mediates social neuroprotection after cerebral ischemia. Stroke 2011, 42:3606-3611.
60. Katoh A., Shoguchi K., Matsuoka H., Yoshimura M., Ohkubo J.I., Matsuura T., et al. Fluorescent visualisation of the hypothalamic oxytocin neurones activated by cholecystokinin-8 in rats expressing c-fos-enhanced green fluorescent protein and oxytocin-monomeric red fluorescent protein 1 fusion transgenes. J. Neuroendocrinol. 2014, 26:341-347.
61. Kavaliers M., Choleris E. Sociality, pathogen avoidance, and the neuropeptides oxytocin and arginine vasopressin. Psychol. Sci. 2011, 22:1367-1374.
62. Kelley K.W., Weigent D.A., Kooijman R. Protein hormones and immunity. Brain Behav. Immun. 2007, 21:384-392.
63. Kim Y.S., Kwon J.S., Hong M.H., Kang W.S., Jeong H.Y., Kang H.J., et al. Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin. BMC Cell Biol. 2013, 14:38.
64. Knobloch H.S., Grinevich V. Evolution of oxytocin pathways in the brain of vertebrates. Front. Behav. Neurosci. 2014, 8:31.
65. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., et al. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
66. Kucharski J., Jana B. Immuno-endocrine mechanisms connected with the creation of corpora lutea persistent in animal ovaries. Pol. J. Vet. Sci. 2005, 8:255-259.
67. Kurlaev P.P., Gavrilenko V.G. Correction of hyperglycemia in diabetic patients with postinjection abscesses. Khirurgiia (Mosk) 2001, 39-41.
68. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J. Chem. Neuroanat. 1996, 10:53-71.
69. Landgraf R., Malkinson T., Horn T., Veale W.L., Lederis K., Pittman Q.J. Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am. J. Phys. 1990, 258:R155-R159.
70. Landgraf R., Malkinson T.J., Veale W.L., Lederis K., Pittman Q.J. Vasopressin and oxytocin in rat brain in response to prostaglandin fever. Am. J. Phys. 1990, 259:R1056-R1062.
71. Landgraf R., Neumann I., Holsboer F., Pittman Q.J. Interleukin-1 beta stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur. J. Neurosci. 1995, 7:592-598.
72. Lerer E., Levi S., Israel S., Yaari M., Nemanov L., Mankuta D., et al. Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 2010, 3:293-302.
73. Lopatina O., Yoshihara T., Nishimura T., Zhong J., Akther S., Fakhrul A.A., et al. Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease. Front. Behav. Neurosci. 2014, 8:133.
74. Lu J., Reese J., Zhou Y., Hirsch E. Progesterone-induced activation of membrane-bound progesterone receptors in murine macrophage cells. J. Endocrinol. 2015, 224:183-194.
75. Ludwig M., Sabatier N., Bull P.M., Landgraf R., Dayanithi G., Leng G. Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites. Nature 2002, 418:85-89.
76. Maccio A., Madeddu C., Chessa P., Panzone F., Lissoni P., Mantovani G. Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity. In Vivo. 2010, 24:157-163.
77. Makani V., Sultana R., Sie K.S., Orjiako D., Tatangelo M., Dowling A., et al. Annexin A1 complex mediates oxytocin vesicle transport. J. Neuroendocrinol 2013.
78. Martines E.V., Reggiani P.C., Camihort G., Luna G., Zappa M.F., Brown O.A., et al. The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies. Neuroimmunomodulation 2013, 20:256-263.
79. Marvel F.A., Chen C.C., Badr N., Gaykema R.P., Goehler L.E. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav. Immun. 2004, 18:123-134.
80. McQuaid R.J., McInnis O.A., Abizaid A., Anisman H. Making room for oxytocin in understanding depression. Neurosci. Biobehav. Rev. 2014, 45:305-322.
81. Miller V.M., Zhu Y., Bucher C., McGinnis W., Ryan L.K., Siegel A., et al. Gestational flu exposure induces changes in neurochemicals, affiliative hormones and brainstem inflammation, in addition to autism-like behaviors in mice. Brain Behav. Immun. 2013, 33:153-163.
82. Mizuno A., Cherepanov S.M., Kikuchi Y., Fakhrul A.A., Akther S., Deguchi K., et al. Lipo-oxytocin-1, a novel oxytocin analog conjugated with two palmitoyl groups, has long-lasting effects on anxiety-related behavior and social avoidance in CD157 knockout mice. Brain Sci. 2015, 5:3-13.
83. Moller A., Hansen B.L., Hansen G.N., Hagen C. Autoantibodies in sera from patients with multiple sclerosis directed against antigenic determinants in pituitary growth hormone-producing cells and in structures containing vasopressin/oxytocin. J. Neuroimmunol. 1985, 8:177-184.
84. Morin V., Del Castillo J.R., Authier S., Ybarra N., Otis C., Gauvin D., et al. Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat. J. Pharm. Pharm. Sci. 2008, 11:12-24.
85. Morita T., Shibata K., Kikkawa F., Kajiyama H., Ino K., Mizutani S. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. Int. J. Cancer 2004, 109:525-532.
86. Mravec B., Lackovicova L., Pirnik Z., Bizik J., Bundzikova J., Hulin I., et al. Brain response to induced peripheral cancer development in rats: dual fos-tyrosine hydroxylase and fos-oxytocin immunohistochemistry. Endocr. Regul. 2009, 43:3-11.
87. Nation D.A., Szeto A., Mendez A.J., Brooks L.G., Zaias J., Herderick E.E., et al. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice. Psychosom. Med. 2010, 72:376-382.
88. Neumann I.D., Landgraf R. Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35:649-659.
89. Norman G.J., Cacioppo J.T., Morris J.S., Karelina K., Malarkey W.B., Devries A.C., et al. Selective influences of oxytocin on the evaluative processing of social stimuli. J. Psychopharmacol. 2011, 25:1313-1319.
90. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
91. Oliveira-Pelegrin G.R., Saia R.S., Carnio E.C., Rocha M.J. Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages. Neuroimmunomodulation 2013, 20:65-71.
92. Ott I., Scott J.C. The galactogogue action of the thymus and corpus luteum. Proc. Soc. Exp. Biol. Med. Proc. Soc. Exp. Biol. 1910, 8:49-53.
93. Pequeux C., Breton C., Hagelstein M.T., Geenen V., Legros J.J. Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung. Lung Cancer 2005, 50:177-188.
94. Peters S., Slattery D.A., Uschold-Schmidt N., Reber S.O., Neumann I.D. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology 2014, 42:225-236.
95. Petersson M. Opposite effects of oxytocin on proliferation of osteosarcoma cell lines. Regul. Pept. 2008, 150:50-54.
96. Pilar Carrera M., Ramirez-Exposito M.J., Duenas B., Dolores Mayas M., Jesus Garcia M., De la Chica S., et al. Insulin-regulated aminopeptidase/placental leucil Aminopeptidase (IRAP/P-lAP) and angiotensin IV-forming activities are modified in serum of rats with breast cancer induced by N-methyl-nitrosourea. Anticancer Res. 2006, 26:1011-1014.
97. Pittman Q.J. A neuro-endocrine-immune symphony. J. Neuroendocrinol. 2011, 23:1296-1297.
98. Pittman Q.J., Riphagen C.L., Lederis K. Release of immunoassayable neurohypophyseal peptides from rat spinal cord, in vivo. Brain Res. 1984, 300:321-326.
99. Pont J.N., McArdle C.A., Lopez B.A. Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells. Mol. Endocrinol. 2012, 26:1743-1756.
100. Porges S.W. The polyvagal theory: phylogenetic substrates of a social nervous system. Int. J. Psychophysiol. 2001, 42:123-146.
101. Poutahidis T., Kearney S.M., Levkovich T., Qi P., Varian B.J., Lakritz J.R., et al. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS ONE 2013, 8.
102. Rettori V., Fernandez-Solari J., Mohn C., Zorrilla Zubilete M.A., de la Cal C., Prestifilippo J.P., et al. Nitric oxide at the crossroad of immunoneuroendocrine interactions. Ann. N. Y. Acad. Sci. 2009, 1153:35-47.
103. Reversi A., Cassoni P., Chini B. Oxytocin receptor signaling in myoepithelial and cancer cells. J. Mammary Gland Biol. Neoplasia 2005, 10:221-229.
104. Ross K.M., McDonald-Jones G., Miller G.E. Oxytocin does not attenuate the ex vivo production of inflammatory cytokines by lipopolysaccharide-activated monocytes and macrophages from healthy male and female donors. Neuroimmunomodulation 2013, 20:285-293.
105. Ruggeri B., Sarkans U., Schumann G., Persico A.M. Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology 2014, 231:1201-1216.
106. Saji F., Samejima Y., Kamiura S., Sawai K., Shimoya K., Kimura T. Cytokine production in chorioamnionitis. J. Reprod. Immunol. 2000, 47:185-196.
107. Savino W., Arzt E., Dardenne M. Immunoneuroendocrine connectivity: the paradigm of the thymus-hypothalamus/pituitary axis. Neuroimmunomodulation 1999, 6:126-136.
108. Servais S., Baudoux E., Brichard B., Bron D., Debruyn C., De Hemptinne D., et al. Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica 2014.
109. Shattuck E.C., Muehlenbein M.P. Human sickness behavior: ultimate and proximate explanations. Am. J. Phys. Anthropol. 2015, 157:1-18.
110. Sherman S.K., Maxwell J.E., Carr J.C., Wang D., Bellizzi A.M., Sue O'dorisio M., et al. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors. Clin. Exp. Metastasis 2014.
111. Skorobogatykh Iu I., Perunova N.B., Kurlaev P.P., Bukharin O.V. Experimental study of combination of ciprofloxacin and oxytocin on formation of biofilms by opportunistic bacteria. Zh. Mikrobiol. Epidemiol. Immunobiol. 2010, 3-7.
112. Souza-Moreira L., Campos-Salinas J., Caro M., Gonzalez-Rey E. Neuropeptides as pleiotropic modulators of the immune response. Neuroendocrinology 2011, 94:89-100.
113. Stabile A.M., Moreto V., Antunes-Rodrigues J., Carnio E.C. Central but not systemic inhibition of inducible nitric oxide synthase modulates oxytocin release during endotoxemic shock. Peptides 2010, 31:706-711.
114. Summy-Long J.Y., Hu S. Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1532-R1545.
115. Szeto A., Nation D.A., Mendez A.J., Dominguez-Bendala J., Brooks L.G., Schneiderman N., et al. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1495-E1501.
116. Tas Hekimoglu A., Toprak G., Akkoc H., Evliyaoglu O., Ozekinci S., Kelle I. Oxytocin ameliorates remote liver injury induced by renal ischemia-reperfusion in rats. Korean J. Physiol. Pharmacol. 2013, 17:169-173.
117. Ueta Y., Kannan H., Higuchi T., Negoro H., Yamaguchi K., Yamashita H. Activation of gastric afferents increases noradrenaline release in the paraventricular nucleus and plasma oxytocin level. J. Auton. Nerv. Syst. 2000, 78:69-76.
118. Veening J.G., Olivier B. Intranasal administration of oxytocin: behavioral and clinical effects, a review. Neurosci. Biobehav. Rev. 2013, 37:1445-1465.
119. Wang Y.F., Hatton G.I. Mechanisms underlying oxytocin-induced excitation of supraoptic neurons: prostaglandin mediation of actin polymerization. J. Neurophysiol. 2006, 95:3933-3947.
120. Wang Y.F., Hatton G.I. Astrocytic plasticity and patterned oxytocin neuronal activity: dynamic interactions. J. Neurosci. 2009, 29:1743-1754.
121. Wang Y.F., Zhu H. Mechanisms underlying astrocyte regulation of hypothalamic neuroendocrine neuron activity. Sheng Li Ke Xue Jin Zhan 2014, 45:177-184.
122. Wang Y.F., Ponzio T.A., Hatton G.I. Autofeedback effects of progressively rising oxytocin concentrations on supraoptic oxytocin neuronal activity in slices from lactating rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290:R1191-R1198.
123. Wang Y., Wang P., Ma H., Zhu W. Developments around the bioactive diketopiperazines: a patent review. Exp. Opin. Ther. Pat. 2013, 23:1415-1433.
124. Welch M.G., Margolis K.G., Li Z., Gershon M.D. Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. Am. J. Physiol. Gastrointest Liver Physiol 2014.
125. Yaksh T.L., Hobo S., Peters C., Osborn K.G., Richter P.J., Rossi S.S., et al. Preclinical toxicity screening of intrathecal oxytocin in rats and dogs. Anesthesiology 2014, 120:951-961.
126. Yamashita M., Takayanagi Y., Yoshida M., Nishimori K., Kusama M., Onaka T. Involvement of prolactin-releasing peptide in the activation of oxytocin neurones in response to food intake. J. Neuroendocrinol. 2013, 25:455-465.
127. Yang H., Wang L., Han L., Wang S.C. Nonsocial functions of hypothalamic oxytocin. ISRN Neurosci. 2013, 2013:13.
128. Yang H., Wang L., Ju G. Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. Neuroimmunomodulation 1997, 4:120-127.
129. Yue C., Ponzio T.A., Fields R.L., Gainer H. Oxytocin and vasopressin gene expression and RNA splicing patterns in the rat supraoptic nucleus. Physiol. Genomics 2008, 35:231-242.
130. Zhong M., Clarke S., Vo B.T., Khan S.A. The essential role of Gialpha2 in prostate cancer cell migration. Mol. Cancer Res. 2012, 10:1380-1388.